new delhi the hyderabadbased covid vaccine manufacturing company bharat biotech submitted data from the phase iii clinical trials of covaxin to drugs controller general of india dcgi over the weekend according to government sourceswe have received the data from the phase iii trials a senior government official confirmedbharat biotechs covaxin is one of the three vaccines which are currently being used in india the phase iii data of its vaccine have been questioned various times and that is what makes the data crucial which will ascertain the efficacy of the vaccinethe company has developed the vaccine in association with the indian council of medical research icmrin a press briefing a few days ago by the union health ministry dr v k paul who is a member health niti aayog and also the head of the covid task force of the country said that the company would be submitting the data within seven to eight days